CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Intercept Pharmaceuticals Inc Company Snapshot
Intercept Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Intercept Pharmaceuticals Inc with three other companies in this sector in the United States: Opexa Therapeutics, Inc. (2015 sales of $2.56 million of which 100% was Cellular Therapies), Procyon Corporation ($2.77 million ), and Innocoll Holdings PLC ($2.85 million of which 100% was Surgical Equipment).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Intercept Pharmaceuticals Inc
  Stock Performance Chart for Intercept Pharmaceuticals Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (12/2/2016): 99.70
(Figures in U.S. Dollars)
1 Week -13.9%   13 Weeks 1.9%  
4 Weeks -33.9%   52 Weeks -35.8%  
 
Intercept Pharmaceuticals Inc Key Data:
  Ticker: ICPT Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 2,782,000
(Year Ending Jan 2016).
Employees: 405
  Currency: U.S. Dollars Market Cap: 2,471,657,914
  Fiscal Yr Ends: December Shares Outstanding: 24,790,952
  Share Type: Common Closely Held Shares: 7,169,950
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.